[Form 3] Kindly MD, Inc. Initial Statement of Beneficial Ownership
Kindly MD, Inc. (NAKA) Form 3: Tyler Matthew Evans filed an initial Form 3 disclosing direct beneficial ownership of 178,571 shares of Kindly MD common stock. The filing lists Evans as a Director, an Officer (Chief Investment Officer), and not a 10% owner. The Form 3 reports the event date of 08/14/2025 and is signed on 08/22/2025.
Kindly MD, Inc. (NAKA) Modulo 3: Tyler Matthew Evans ha presentato un Modulo 3 iniziale rivelando la titolarità diretta di 178.571 azioni di azioni ordinarie di Kindly MD. La documentazione indica Evans come Direttore, Dirigente (Chief Investment Officer) e non come detentore del 10% o più. Il Modulo 3 riporta la data dell'evento 14/08/2025 ed è firmato il 22/08/2025.
Kindly MD, Inc. (NAKA) Formulario 3: Tyler Matthew Evans presentó un Formulario 3 inicial en el que declara la propiedad beneficiosa directa de 178.571 acciones de acciones ordinarias de Kindly MD. La presentación lista a Evans como Director, Ejecutivo (Chief Investment Officer) y no como propietario del 10%. El Formulario 3 indica la fecha del evento 14/08/2025 y está firmado el 22/08/2025.
Kindly MD, Inc. (NAKA) 양식 3: Tyler Matthew Evans� Kindly MD 보통� 178,571�� 대� 직접� 실소유권� 공개하는 초기 양식 3� 제출했습니다. 제출서에� Evans� 이사이자 ѫ(Chief Investment Officer)으로 기재하였으며, 10% 이상 보유자는 아닙니다. 양식 3은 사건일자� 2025-08-14� 보고하고 서명일은 2025-08-22입니�.
Kindly MD, Inc. (NAKA) Formulaire 3 : Tyler Matthew Evans a déposé un formulaire 3 initial déclarant la propriété bénéficiaire directe de 178 571 actions d'actions ordinaires de Kindly MD. Le dépôt indique Evans comme Administrateur, Dirigeant (Chief Investment Officer) et non comme détenteur de 10 %. Le formulaire 3 signale la date de l'événement 14/08/2025 et est signé le 22/08/2025.
Kindly MD, Inc. (NAKA) Formular 3: Tyler Matthew Evans reichte ein initiales Formular 3 ein, in dem er die direkte wirtschaftliche Eigentümerschaft von 178.571 Aktien der Stammaktien von Kindly MD angibt. Die Einreichung führt Evans als Direktor, Offizier (Chief Investment Officer) und nicht als 10%-Eigentümer auf. Das Formular 3 nennt das Ereignisdatum 14.08.2025 und ist am 22.08.2025 unterschrieben.
- Insider roles disclosed: Reporting person identified as Director and Chief Investment Officer
- Exact share count reported: 178,571 shares of common stock disclosed
- Form 3 filed and signed: Filing includes signature and cites Exhibit 24 (Power of Attorney)
- None.
Insights
TL;DR: Routine initial disclosure: officer/director reports ownership of 178,571 shares; no derivatives or 10% ownership indicated.
This Form 3 is an initial Section 16 filing that notifies the market of insider ownership by Tyler Matthew Evans. The report is limited to non-derivative common stock holdings (178,571 shares) and specifies Evans' roles as director and Chief Investment Officer. No derivative securities, amendments, or joint filings are disclosed, indicating a straightforward ownership disclosure without immediate market-moving detail.
TL;DR: Governance disclosure completed: insider relationship and share count reported; standard compliance action.
The filing fulfills Section 16 reporting obligations by identifying the reporting person, official roles, and exact share count. It includes a signed certification and reference to a Power of Attorney (Exhibit 24). The absence of indirect ownership descriptions or derivative positions suggests a clean, direct holding structure for this reporting person.
Kindly MD, Inc. (NAKA) Modulo 3: Tyler Matthew Evans ha presentato un Modulo 3 iniziale rivelando la titolarità diretta di 178.571 azioni di azioni ordinarie di Kindly MD. La documentazione indica Evans come Direttore, Dirigente (Chief Investment Officer) e non come detentore del 10% o più. Il Modulo 3 riporta la data dell'evento 14/08/2025 ed è firmato il 22/08/2025.
Kindly MD, Inc. (NAKA) Formulario 3: Tyler Matthew Evans presentó un Formulario 3 inicial en el que declara la propiedad beneficiosa directa de 178.571 acciones de acciones ordinarias de Kindly MD. La presentación lista a Evans como Director, Ejecutivo (Chief Investment Officer) y no como propietario del 10%. El Formulario 3 indica la fecha del evento 14/08/2025 y está firmado el 22/08/2025.
Kindly MD, Inc. (NAKA) 양식 3: Tyler Matthew Evans� Kindly MD 보통� 178,571�� 대� 직접� 실소유권� 공개하는 초기 양식 3� 제출했습니다. 제출서에� Evans� 이사이자 ѫ(Chief Investment Officer)으로 기재하였으며, 10% 이상 보유자는 아닙니다. 양식 3은 사건일자� 2025-08-14� 보고하고 서명일은 2025-08-22입니�.
Kindly MD, Inc. (NAKA) Formulaire 3 : Tyler Matthew Evans a déposé un formulaire 3 initial déclarant la propriété bénéficiaire directe de 178 571 actions d'actions ordinaires de Kindly MD. Le dépôt indique Evans comme Administrateur, Dirigeant (Chief Investment Officer) et non comme détenteur de 10 %. Le formulaire 3 signale la date de l'événement 14/08/2025 et est signé le 22/08/2025.
Kindly MD, Inc. (NAKA) Formular 3: Tyler Matthew Evans reichte ein initiales Formular 3 ein, in dem er die direkte wirtschaftliche Eigentümerschaft von 178.571 Aktien der Stammaktien von Kindly MD angibt. Die Einreichung führt Evans als Direktor, Offizier (Chief Investment Officer) und nicht als 10%-Eigentümer auf. Das Formular 3 nennt das Ereignisdatum 14.08.2025 und ist am 22.08.2025 unterschrieben.